Apollo Endosurgery, Inc. (APEN) News
Filter APEN News Items
APEN News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
APEN News Highlights
- APEN's 30 day story count now stands at 2.
- Over the past 25 days, the trend for APEN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest APEN News From Around the Web
Below are the latest news stories about APOLLO ENDOSURGERY INC that investors may wish to consider to help them evaluate APEN as an investment opportunity.
Apollo Endosurgery Full Year 2022 Earnings: Revenues Beat Expectations, EPS LagsApollo Endosurgery ( NASDAQ:APEN ) Full Year 2022 Results Key Financial Results Revenue: US$76.9m (up 22% from FY... |
Does This Valuation Of Apollo Endosurgery, Inc. (NASDAQ:APEN) Imply Investors Are Overpaying?Key Insights Apollo Endosurgery's estimated fair value is US$7.40 based on 2 Stage Free Cash Flow to Equity Apollo... |
Analysts Are Downgrading These 10 StocksIn this article, we will discuss the 10 stocks recently downgraded by analysts. If you want to see more such stocks on the list, you can directly visit Analysts Are Downgrading These 5 Stocks. Microsoft Corporation (NASDAQ:MSFT) is in the news after the company posted fiscal Q2 results. The company’s revenue outlook for the March […] |
Apollo Endosurgery Announces Two Important Milestones in the Advancement of Endoscopic Procedures for Patients Living with ObesityApollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced today that the MERIT trial, published in The Lancet earlier this year(1), was selected as 2022 Top Story in Gastroenterology.(2) Additionally, the American Society for Metabolic and Bariatric Surgery (ASMBS) formally added four Apollo systems to its list of FDA Approved Bariatric Devices |
Boston Scientific's (BSX) New Buyout to Expand its PortfolioBoston Scientific's (BSX) latest buyout is expected to boost its Endoscopy business by adding Apollo Endosurgery's product portfolio, which includes devices used during ELS procedures. |
Bed Bath & Beyond (BBBY) Stock Rebounds After Black Friday WoesBed Bath & Beyond (BBBY) stock is bouncing back on Tuesday after the retail company's shares took a dive Monday on poor Black Friday sales. |
Why Is Otonomy (OTIC) Stock Up 97% Today?Otonomy (OTIC) stock is on the move Tuesday with heavy trading despite a lack of news from the biopharmaceutical company. |
Apollo Endosurgery (APEN) Stock Soars 65% on Boston Scientific DealApollo Endosurgery is about to be acquired by Boston Scientific. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayGood morning! |
Investors Liked These 2 Stock Buyouts TuesdayInvestors settled in for a largely quiet trading session on Tuesday. With a speech expected from Federal Reserve chair Jerome Powell on Wednesday, most market participants were content to wait and see what the central banker will say about the future path of monetary policy. |